Effect of Fetuin A in Hemodialysis Patients

University of Shizuoka300 enrolled

Overview

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Hemodialysis Malnutrition

Eligibility

Sex: ALLMin age: 0 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Hemodialysis for at least 6 months Exclusion Criteria: * Disabled patients

Locations (1)

Maruyama Hospital

Hamamatsu, Shizuoka, Japan

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.